Collplant Biotechnologies Ltd

NASDAQ CLGN

Data sourced from iex and EODHD
Download Data

Collplant Biotechnologies Ltd Income Statement 2014 - 2024

This table shows the Income Statement for Collplant Biotechnologies Ltd going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30
Revenue
M 0 0 0 10 0 0 0 0 0 0 0 1 15 1 4 1 0 0 1 1 4 4 0 0 0 0 0 0 0 0 0 - - - - - - - - -
Cost of Revenue
M 1 1 0 1 0 0 0 0 0 1 0 0 1 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Gross Profit
M -1 0 0 10 0 0 0 0 0 0 0 0 14 0 3 0 0 0 0 0 4 4 0 0 0 0 0 0 0 0 0 - - - - - - - - -
Operating Expenses
M 4 5 4 4 4 4 5 4 4 4 3 3 4 3 2 2 3 3 2 2 3 3 2 1 2 2 1 2 1 2 2 - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 1 1 2 1 2 2 2 2 2 1 1 1 2 2 1 1 1 1 1 1 1 3 3 3 1 2 1 0 0 - 2 - - 3 2 1 - 11 - 1
Research and Development (R&D) Expenses
M 3 3 3 3 2 2 3 3 2 2 2 2 2 1 1 1 2 2 1 1 2 2 1 1 1 1 1 1 1 0 1 1 1 - 1 1 1 - 1 1
Other Operating Expenses
M 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -2 -2 -2 0 -1 0 0 0 - -1 - - - - - - - - -
Costs and Expenses
M 3 5 4 3 3 3 5 4 4 3 3 3 3 3 1 1 2 2 1 1 3 3 2 1 2 2 1 2 1 - - - - - - - - - - -
Operating Income
M -5 -5 -5 6 -4 -4 -5 -4 -4 -4 -3 -3 10 -3 1 -2 -3 -3 -2 -2 1 1 -2 -1 -2 -2 -1 -2 -1 -2 -2 -2 -2 - -1 -1 -1 - -1 -1
Interest Expense
M 0 - - - 0 0 0 0 0 0 0 0 0 1 0 0 2 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0
Non-operating Income/Expense
M 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -3 -3 -2 0 0 0 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0 1 0 0
EBT
M -5 -5 -4 6 -4 -4 -4 -4 -4 -4 -3 -3 10 -3 1 -2 -4 -4 -3 -2 1 1 -1 -2 -2 -2 -1 -2 -1 -2 -2 -2 -2 - -1 -1 -1 - -1 -1
Income Tax Provision
M 0 - - - 0 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 -1 -1 0 0 0 15 0 0 0 0 0 0 0 - 0 0 0 - 0 0
Income after Tax
M -5 - - - -4 -4 -4 -4 -4 -4 -3 -3 10 -3 1 -2 -7 -7 -3 -1 2 2 -2 -2 -2 -17 -1 -2 -1 -2 -2 -2 -2 - -1 -1 -1 - -1 -1
Non-Controlling Interest
M - - - 0 -9 -10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Net Income
M - - - 6 6 6 -4 -4 -4 -4 -3 -3 10 -3 1 -2 -2 -4 -3 -2 -2 4 -5 -6 -2 -6 3 -2 -1 - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 11,452,672.00 11,452,672.00 11,443,023.00 11,777,139.00 11,270,948.00 11,270,948.00 11,173,879.00 11,086,481.00 10,783,065.00 4,986,381,000.00 10,502,136.00 10,201,231.00 11,481,163.00 4,986,381,000.00 10,042,857.00 6,958,124.00 4,986,381,000.00 4,986,381,000.00 4,661,879.00 4,661,517.00 233,010,891.00 233,010,891.00 4,592,997.00 4,348,582.00 170,551,850.00 145,002,163.00 2,766,727.00 2,611,973.00 118,299,021.00 98,779,600.00 2,132,436.00 1,943,737.00 92,514,714.00 - 1,776,236.00 1,609,323.00 241,392,352.00 - 1,579,165.00 1,510,444.00
EBITDA
M -5 - -4 6 -3 -3 -4 -4 -4 -4 -3 -3 10 -2 1 -2 1 1 -1 -1 1 1 -1 -1 -2 -2 -1 -2 -1 -2 -2 -2 -2 - -1 -1 -1 - -1 -1
Depreciation and Amortization
M 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0
EBIT
M -5 - -5 6 -4 -4 -5 -4 -4 -4 -3 -3 10 -3 1 -2 1 1 -2 -1 1 1 -1 -1 -2 -2 -1 -2 -1 -2 -2 -2 -2 - -1 -1 -1 - -1 -1
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Tax Rate (Effective)
% 0.00 - - - -5.28 -5.28 6.25 -2.33 -2.38 5.49 -0.81 -1.09 0.19 -5.75 -2.84 2.84 -48.03 -48.03 3.24 9.21 -83.38 -83.38 -29.81 -3.06 -5.35 -898.40 0.16 0.02 0.00 0.64 -0.21 -0.51 -0.04 - -7.25 -0.23 -4.18 - -14.64 -8.72
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - -
Gross Profit Margin
% -253.51 -158.53 -546.51 93.96 24.94 24.94 -6.90 34.85 53.03 -76.77 -1.43 37.92 93.89 39.32 65.26 9.11 10.02 10.02 7.81 25.25 94.76 94.76 66.30 63.55 88.96 94.54 100.00 100.00 100.00 100.00 100.00 - - - - - - - - -
Operating Income Margin
% -1,694.98 -1,694.98 -10,702.33 55.74 -812.70 -812.70 -8,062.07 -6,340.91 -5,709.09 -1,227.10 -2,210.00 -443.27 69.14 -487.07 17.70 -232.44 -645.56 -645.56 -243.45 -262.05 15.88 15.88 -687.08 -767.84 -926.70 -650.42 -1,423.57 -2,828.86 -2,036.11 -3,258.04 -7,333.70 - - - - - - - - -
Net Income Margin
% - - - 56.58 1,330.72 1,330.72 -7,550.00 -6,492.42 -5,848.48 -1,216.77 -2,197.86 -439.65 69.82 -521.54 16.95 -239.49 -364.69 -1,001.14 -472.90 -250.83 -48.61 90.12 -2,153.78 -3,124.86 -925.39 -2,247.67 4,655.71 -2,698.21 -2,056.09 - - - - - - - - - - -
EBITDA Ratio
% -1,600.00 - -10,069.77 58.36 -748.04 -748.04 -7,555.17 -5,945.45 -5,345.45 -1,212.58 -2,051.43 -412.59 70.68 -427.83 21.24 -219.44 142.60 142.60 -219.44 -197.85 15.88 15.88 -451.85 -710.94 -838.77 -650.42 -1,331.94 -2,704.98 -1,896.43 -3,219.54 -7,109.78 - - - - - - - - -
EBIT Ratio
% -1,694.98 - -10,702.33 55.74 -812.70 -812.70 -8,062.07 -6,340.91 -5,709.09 -1,284.84 -2,192.14 -438.49 69.49 -457.63 17.21 -239.25 203.87 203.87 -258.76 -240.26 13.34 13.34 -505.29 -755.28 -877.02 -673.62 -1,423.57 -2,828.86 -2,036.11 -3,279.80 -7,329.35 - - - - - - - - -
EBT Ratio
% -1,568.23 -1,568.23 -10,179.07 56.58 -857.97 -857.97 -7,587.93 -6,492.42 -5,848.48 -1,216.77 -2,197.86 -439.65 69.82 -521.54 16.95 -239.49 -1,001.14 -1,001.14 -472.90 -250.83 23.93 23.93 -596.19 -854.21 -929.40 -621.01 -1,494.68 -2,907.96 -2,060.32 -3,304.50 -7,425.00 - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email